Masimo unveils Masimo W1™: its first-of-a-kind health watch
Category: #health  | By Nikita Chaurasia  | Date: 2022-09-01 |
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Masimo unveils Masimo W1™: its first-of-a-kind health watch

Masimo, a global medical technology company, has recently announced the full market release of its Masimo W1™ health watch for customer use.

As per credible reports, the new watch is a first-of-its-kind and offers accurate, insightful health data and constant measurements in a lifestyle-friendly, personal, wrist-worn wearable.

The Masimo W1 is based on Masimo's decades of expertise in providing noninvasive blood parameter monitoring solutions, including continuous oxygen saturation (SpO2) monitoring.

In addition to this, it will also monitor respiration rate, pulse rate, and hydration index for users wanting to understand their overall health better, stay fit, or share the data with friends and family.

Apparently, with the ability to record 86,400 measurements per day for second-by-second, the Masimo W1 watch demonstrates the future of personal health.

According to sources, the Masimo W1 would be available at its website for direct-to-consumer purchasing.

Speaking on the latest development, Joe Kiani, Founder & CEO of Masimo, stated that with 30+ years of experience in medical monitoring and telemedicine, the firm is delighted to bring the first wearable device to offer detailed & continuous hydration index, pulse oximetry, and other health measurements to its consumers.

The SET tech, a technology on which the newly launched health watch is based, has revolutionized health monitoring, saved lives, and has proven to be cost-effective.

Based on the feedback received during the partial market release phase for the Masimo W1, the firm is confident that this watch will improve lives.

For the unversed, Masimo is well-recognized for its exceptional accuracy and consistency during challenging conditions like low perfusion and motion.

Moreover, the firm is now unveiling a new device with its expertise in signal processing, bio-sensing, and photonics, for consumers who wish to control their physical health, make better health decisions, and monitor their complete physical status.

Paired with secure Bluetooth to the Masimo Health smartphone app, the watch delivers continuous health data and actionable insights with accuracy never heard of in a wearable or watch.

Source Credit - https://www.businesswire.com/news/home/20220831005074/en/Medical-Pioneer-Masimo-Announces-the-Full-Market-Consumer-Release-of-the-Masimo-W1%E2%84%A2-the-First-Watch-to-Offer-Accurate-Continuous-Health-Data

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia     twitter

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More..

More News By Nikita Chaurasia

Fintech firm PayPal to shed around 2000 staff as global economy plummets

Fintech firm PayPal to shed around 2000 staff as global economy plummets

By Nikita Chaurasia

PayPal, the U.S.-based fintech giant, has reportedly announced that it will cut nearly 2000 jobs, approximately 7% of its workforce, as it turns the latest prominent tech company to shed staff in a bid to cut costs. The online payments provider cl...

EasyJet sees a rise in bookings as customers plan their next vacations

EasyJet sees a rise in bookings as customers plan their next vacations

By Nikita Chaurasia

British multinational low-cost airline group, EasyJet, has reported a record surge in bookings for the month of January as people prioritized their travel plans for the coming year. The news comes as airlines world over start to show signs that they&...

Dr. Reddy’s becomes India’s second biggest drugmaker by sales

Dr. Reddy’s becomes India’s second biggest drugmaker by sales

By Nikita Chaurasia

Dr. Reddy's Laboratories Ltd. and Cipla Ltd. surpassed Aurobindo Pharma to rank as the 2nd and 3rd largest drug manufacturers in India by sales in the three months that ended on September 30. This was the first change in the pecking order of the ...